News

Radius Specialty Solutions Launches RxTouchpoints Subscription-based Reimbursement Support Program

BDI Pharma subsidiary Radius Specialty Solutions, a patient support and data solutions company, announced today the launch of a scalable, comprehensive reimbursement support program for both specialty pharmacies and physician practices. Called RxTouchpoints, this is the first program for specialty pharmacies and practices that allows these organizations to pay only for the reimbursement services they actually need and use.

Read full article

CSL Behring Presents Data on Therapeutic Potential of Idelvion

CSL Behring recently reported new results from its phase III clinical development program designed to evaluate Idelvion®. The findings were presented at the 58th Annual Meeting of the American Society of Hematology (ASH), held December 3-6, 2016, in San Diego, CA.

Read full article

BDI Pharma, Inc. Launches Cloud-based DSCSA Solution

COLUMBIA, S.C., March 17, 2016 /PRNewswire/ -- BDI Pharma, Inc. announced today the launch of its Drug Supply Chain Security Act (DSCSA) compliant solution with partner TraceLink. This new service provides customers a one-stop solution for accessing all T3 compliance data from BDI Pharma (transaction information, transaction history and transaction statements) in one central repository that will be retained for a minimum of six years, as is required by the DSCSA.

Read full article

BDI Pharma, Inc. Launches New Website

COLUMBIA, S.C., Nov. 18, 2015 /PRNewswire/ -- BDI Pharma, Inc., the nation's fastest growing, independently owned specialty pharmaceutical distributor today announced the launch of its newly redesigned website at www.bdipharma.com. The new site offers an intuitive user interface seamlessly integrating product searches along with information gathering for the company's customized programs and solutions.

Read full article

BDI Pharma, Inc. Chosen as Authorized Distributor for Coagadex®

COLUMBIA, S.C., Nov. 2, 2015 /PRNewswire/ -- BDI Pharma, Inc., the nation's fastest growing, independently owned specialty pharmaceutical distributor, today announced it has been selected by Bio Products Laboratory (BPL) as an Authorized Distributor of Record (ADR) for Coagadex (Coagulation Factor X, Human).

Read full article